Aquinox Pharmaceuticals Initiates Patient Dosing in the Phase 2 Clinical Trial …
Aquinox Pharmaceuticals Initiates Patient Dosing in the Phase 2 Clinical Trial … … pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology, announced today that it has initiated dosing in a Phase 2 clinical trial of AQX-1125 for the treatment of atopic … Read more on Virtual-Strategy Magazine (press release) …
Aquinox Pharmaceuticals Initiates Patient Dosing in the Phase 2 Clinical Trial … Read More »